Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results
Inv. presentation
Appointed director

Ovid Therapeutics Inc. (OVID) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/27/2023 4 Tardio Jason (COO) has filed a Form 4 on Ovid Therapeutics Inc.
Txns: Granted 175,000 options to buy @ $2.5, valued at $437.5k
02/27/2023 4 Rona Jeffrey A (CBFO) has filed a Form 4 on Ovid Therapeutics Inc.
Txns: Granted 175,000 options to buy @ $2.5, valued at $437.5k
02/27/2023 4 Poole Robert Michael (Director) has filed a Form 4 on Ovid Therapeutics Inc.
Txns: Granted 15,000 options to buy @ $2.5, valued at $37.5k
02/27/2023 4 Perone Thomas Michael (General Counsel, Secretary) has filed a Form 4 on Ovid Therapeutics Inc.
Txns: Granted 175,000 options to buy @ $2.5, valued at $437.5k
02/27/2023 4 LEVIN JEREMY M (CEO) has filed a Form 4 on Ovid Therapeutics Inc.
Txns: Granted 600,000 options to buy @ $2.5, valued at $1.5M
02/27/2023 4 Friedman Bart (Director) has filed a Form 4 on Ovid Therapeutics Inc.
Txns: Granted 15,000 options to buy @ $2.5, valued at $37.5k
02/27/2023 4 Fitzgerald Kevin Joseph (Director) has filed a Form 4 on Ovid Therapeutics Inc.
Txns: Granted 15,000 options to buy @ $2.5, valued at $37.5k
02/27/2023 4 Duncan Barbara Gayle (Director) has filed a Form 4 on Ovid Therapeutics Inc.
Txns: Granted 15,000 options to buy @ $2.5, valued at $37.5k
02/27/2023 4 Bernstein Karen (Director) has filed a Form 4 on Ovid Therapeutics Inc.
Txns: Granted 15,000 options to buy @ $2.5, valued at $37.5k
09/14/2022 4 Tardio Jason (COO) has filed a Form 4 on Ovid Therapeutics Inc.
Txns: Sold 17,344 shares @ $2.15, valued at $37.3k
07/06/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/12/2022 4 Friedman Bart (Director) has filed a Form 4 on Ovid Therapeutics Inc.
Txns: Granted 69,424 options to buy @ $3.22, valued at $223.5k
04/12/2022 4 Tardio Jason (COO) has filed a Form 4 on Ovid Therapeutics Inc.
Txns: Granted 87,498 options to buy @ $3.22, valued at $281.7k
Granted 10,000 options to buy @ $3.22, valued at $32.2k
04/12/2022 4 LEVIN JEREMY M (CEO) has filed a Form 4 on Ovid Therapeutics Inc.
Txns: Granted 423,244 options to buy @ $3.22, valued at $1.4M
04/12/2022 4 Rona Jeffrey A (CBFO) has filed a Form 4 on Ovid Therapeutics Inc.
Txns: Granted 194,399 options to buy @ $3.22, valued at $626k
Granted 10,000 options to buy @ $3.22, valued at $32.2k
04/12/2022 4 Perone Thomas Michael (General Counsel, Secretary) has filed a Form 4 on Ovid Therapeutics Inc.
Txns: Granted 25,399 options to buy @ $3.22, valued at $81.8k
Granted 10,000 options to buy @ $3.22, valued at $32.2k
04/12/2022 4 Duncan Barbara Gayle (Director) has filed a Form 4 on Ovid Therapeutics Inc.
Txns: Granted 21,347 options to buy @ $3.22, valued at $68.7k
04/12/2022 4 Bernstein Karen (Director) has filed a Form 4 on Ovid Therapeutics Inc.
Txns: Granted 69,424 options to buy @ $3.22, valued at $223.5k
02/04/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/04/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/04/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/04/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/04/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/04/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/04/2022 4 Rona Jeffrey A (CBFO) has filed a Form 4 on Ovid Therapeutics Inc.
Txns: Granted 218,750 options to buy @ $2.72, valued at $595k
02/04/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/04/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/07/2021 4 Fitzgerald Kevin Joseph (Director) has filed a Form 4 on Ovid Therapeutics Inc.
Txns: Granted 30,000 options to buy @ $3.44, valued at $103.2k
10/07/2021 3 Fitzgerald Kevin Joseph (Director) has filed a Form 3 on Ovid Therapeutics Inc.
07/16/2021 4 Rakhit Amit (President and CMO) has filed a Form 4 on Ovid Therapeutics Inc.
Txns: Sold 34,017 shares @ $3.71, valued at $126.2k
Exercised 34,017 options to buy @ $1.89, valued at $64.3k
07/13/2021 4 Poole Robert Michael (Director) has filed a Form 4 on Ovid Therapeutics Inc.
Txns: Granted 30,000 options to buy @ $3.94, valued at $118.2k
07/12/2021 3 Poole Robert Michael (Director) has filed a Form 3 on Ovid Therapeutics Inc.
07/01/2021 4 Tardio Jason (Chief Commercial Officer) has filed a Form 4 on Ovid Therapeutics Inc.
Txns: Granted 50,000 options to buy @ $3.95, valued at $197.5k
06/11/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy